LEADER 02933nam 2200577 a 450 001 9910457743603321 005 20200520144314.0 010 $a1-283-29339-0 010 $a9786613293398 010 $a1-935281-42-9 035 $a(CKB)2550000000049566 035 $a(EBL)782031 035 $a(OCoLC)756484278 035 $a(SSID)ssj0000538531 035 $a(PQKBManifestationID)12251361 035 $a(PQKBTitleCode)TC0000538531 035 $a(PQKBWorkID)10559720 035 $a(PQKB)10615215 035 $a(MiAaPQ)EBC782031 035 $a(Au-PeEL)EBL782031 035 $a(CaPaEBR)ebr10506601 035 $a(CaONFJC)MIL329339 035 $a(EXLCZ)992550000000049566 100 $a20110622d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEmerging cancer therapeutics$hVolume 2, issue 2$iLeukemia$b[electronic resource] /$fUday R. Popat, guest editor 210 $aNew York $cDemos Medical$dc2011 215 $a1 online resource (266 p.) 225 1 $aEmerging cancer therapeutics,$x2151-4194 ;$vv. 2, issue 2 300 $aDescription based upon print version of record. 311 $a1-933864-68-0 320 $aIncludes bibliographical references and index. 327 $aHematopathology and diagnostic studies in leukemia / Carlos Bueso-Ramos and Wesley Greaves -- Acute myeloid leukemia / Roland B. Walter and Elihu H. Estey -- Chronic myeloid leukemia / Elias Jabbour, Hagop Kantarjian, and Jorge Cortes -- Adult acute lymphoblastic leukemia / Anna Z. Castleton and Adele K. Fielding -- Acute promyelocytic leukemia / Martin Tallman -- The myelodysplastic syndromes / Yanis Boumber and Guillermo Garcia-Manero -- Myelofibrosis / Fabio P.S. Santos and Srdan Verstovsek -- Chronic lymphocytic leukemia / Preetesh Jain and Kanti R. Rai -- Reduced-intensity allogeneic transplantation / Uday Popat -- Alternative donor transplantation for adult leukemia / Melhem Solh and Navneet S. Majhail -- Immunotherapy for leukemia / Caroline Arber, Barbara Savoldo, and Gianpietro Dotti -- Novel and targeted therapies in leukemia / Amber Fullmer, Hagop Kantarjian, and Elias Jabbour -- Infections in patients with leukemia / Shashank S. Ghantoji and Roy F. Chemaly. 330 $aThis issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of leukemia treatment. Leukemia treatment has undergone major change over the course of the past few years and Leukemia address 410 0$aEmerging cancer therapeutics ;$vv. 2, issue 2. 606 $aLeukemia 608 $aElectronic books. 615 0$aLeukemia. 676 $a616.99/419 701 $aPopat$b Uday R$01035108 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457743603321 996 $aEmerging cancer therapeutics$92454612 997 $aUNINA